Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Proteome-wide analysis of protein abundance and turnover remodelling during oncogenic transformation of human breast epithelial cells.

Ly T, Endo A, Brenes A, Gierlinski M, Afzal V, Pawellek A, Lamond AI.

Wellcome Open Res. 2018 May 2;3:51. doi: 10.12688/wellcomeopenres.14392.1. eCollection 2018.


Characterisation of the biflavonoid hinokiflavone as a pre-mRNA splicing modulator that inhibits SENP.

Pawellek A, Ryder U, Tammsalu T, King LJ, Kreinin H, Ly T, Hay RT, Hartley RC, Lamond AI.

Elife. 2017 Sep 8;6. pii: e27402. doi: 10.7554/eLife.27402.


Identification of small molecule inhibitors of pre-mRNA splicing.

Pawellek A, McElroy S, Samatov T, Mitchell L, Woodland A, Ryder U, Gray D, Lührmann R, Lamond AI.

J Biol Chem. 2014 Dec 12;289(50):34683-98. doi: 10.1074/jbc.M114.590976. Epub 2014 Oct 3. Erratum in: J Biol Chem. 2015 Mar 6;290(10):6005.


Perturbation of chromatin structure globally affects localization and recruitment of splicing factors.

Schor IE, Llères D, Risso GJ, Pawellek A, Ule J, Lamond AI, Kornblihtt AR.

PLoS One. 2012;7(11):e48084. doi: 10.1371/journal.pone.0048084. Epub 2012 Nov 12.


DNA from bovine papillomavirus type 2 induces warts in a xenograft model.

Pawellek A, Hewlett G, Rosenbruch M, Kreuter J, Rübsamen-Waigmann H.

Virus Res. 2002 Dec;90(1-2):365-70.


Xenograft model for identifying chemotherapeutic agents against papillomaviruses.

Pawellek A, Hewlett G, Kreuter J, Rübsamen-Waigmann H, Weber O.

Antimicrob Agents Chemother. 2001 Apr;45(4):1014-21.


Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.

Rapp B, Pawellek A, Kraetzer F, Schaefer M, May C, Purdie K, Grassmann K, Iftner T.

J Virol. 1997 Sep;71(9):6956-66.

Supplemental Content

Loading ...
Support Center